R2

Europe’s Preventable RSV Winter
New ECDC modelling suggests that protecting newborns against RSV could prevent a substantial share of infant hospitalisations during the first months of life. Under a scenario reaching 90% of newborns with long-acting monoclonal antibodies, 61% of RSV hospitalisations in the first two months could be prevented. Europe has the preventive tools. The challenge is making…

Cardiometabolic care tracks glucose and blood pressure

Europe Has Plans. Implementation Is Lagging

Cardiometabolic care is screening the pieces. It is not yet connecting them

Cardiac amyloidosis is no longer the whole story of protein misfolding

ESCAT v2 Makes Resistance Clinically Actionable

Cardiovascular prevention has a climate blind spot

Beans, lentils and chickpeas are linked to better metabolic health. America still barely eats them

Cardiovascular prevention has a climate blind spot

Cardiovascular prevention asks how you live. It may need to ask where you work
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
